![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Frequency and impact of potential multiple
drug-drug interactions (DDIs) associated with
pangenotypic direct-acting antivirals in patients
receiving opioid substitution therapy
|
|
|
EASL International Liver Congress, June 23-26, 2021
F. Tacke1, G. Niess2, M. Gündogdu2, A. Hintz3, T. Umland3
Charite - Universitatsmedizin Berlin, Department of Hepatology and Gastroenterology, Berlin, Germany, 2Gilead Sciences GmbH, Martinsried / Munich, Germany; 3Alexander Apotheke, Hamburg, Germany
![0626211](../images/062621/062621-4/0626211.gif)
![0626212](../images/062621/062621-4/0626212.gif)
![0626213](../images/062621/062621-4/0626213.gif)
![0626214](../images/062621/062621-4/0626214.gif)
![0626215](../images/062621/062621-4/0626215.gif)
![0626216](../images/062621/062621-4/0626216.gif)
![0626217](../images/062621/062621-4/0626217.gif)
![0626218](../images/062621/062621-4/0626218.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|